Abstracting & Indexing
THE AUTHORS SHOULD CHECK FOLLOWING
UJPR publishes these article types:
All parts of the manuscript should be typewritten in “Times New Roman font” using a font size of 12, double-spaced, with margins of at least one inch on all sides. The manuscript should be prepared and numbered consecutively as follows: Title page, Abstract, Introduction, Materials and methods, Results and discussion, Conclusion, Acknowledgements, Conflict of Interest, References, Tables and Figures.
New, significant, innovative and original findings are suitable as Research papers.
The title page must carry a short title of at most 45 characters. As mentioned above, it should include the name, affiliations and address of the author(s) with whom all the future correspondences will be made. Details like phone numbers and email address should also be given. The footnote must have addresses of all the authors, a single telephone number, and a single e-mail address for the corresponding author. Orcid ID of at least one author should be there.
1*Department, University Name, City, Country, Pincode, orcid id.
2Department, University Name, City, Country, Pincode, orcid id
Corresponding Author E-mail: Corresponding firstname.lastname@example.org
Orcid ID: 0000-000X-XXXX-XXXX
If you do not have an ORCID ID, please register for an ORCID ID at https://orcid.org/register so that you can have a unique identifier which will tie you to your work and distinguish you from other researchers. It is easy, free and will come useful or any manuscript or grant submissions.
An abstract not exceeding 350 words should be provided. Avoid abbreviations and references, and do not include diagrams in abstract. The abstract with keywords should be typed on a separate sheet. Clinical trials should include the trial registration number on the last line of the abstract.
Below the abstract, type 3-6 keywords or short phrases suitable for indexing. List key words in alphabetic order, all lower case, except where necessary.
The introduction should not be an extensive literature review, it should provide sufficient information of the present study without referring to previous work done on the same topic. The last paragraph should address the main objectives of the work.
MATERIALS AND METHODS:
The section should include sufficient technical information to allow the experiments to be reproduced with details of supplier (i.e., company’s name, city, country) and catalogue number when appropriate. Procedural detail that has been published previously should be referred by a reference. When a modified procedure is used, only the author’s modifications of the previously published method should be mentioned. To report experiments on animals, authors should indicate institutional and national guidelines for the care and use of laboratory animals. The methods section must indicate about the protocol was reviewed by the appropriate institutional review body and that each subject used in the project signed a detailed informed consent form.
RESULTS AND DISCUSSION:
Results should be described as concisely in following ways: text, table(s), or figure(s) and illustrations as appropriate. Extensive use of graphs to present data that might be more concisely or more comprehensively presented in the figures or tables should be avoided. The reproducibility and statistical significance of measurements, material or biological data must be included where relevant. Attention should be paid that same data should not be presented in more than one figure or in both a figure and a table.
The discussion should compare the present data to previous findings. There should not be any significant repetition of the experimental procedures or reiteration of the introduction. New hypotheses and clinical recommendations should be clearly identified.
Conclusion should be a short paragraph summarizing the most important finding(s) of the research.
Authors should acknowledge for source of any financial support, gifts, technical assistance and advice received.
CONFLICT OF INTEREST:
Authors must declare any conflict of interest. If there are none, the authors should indicate “No conflict of interest associated with this work”.
Contribution of each author should be mentioned for the work.
Any in-press articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office. All web links and URLs should be given a reference number and included in the reference list rather than within the text of the manuscript. Published conference abstracts, numbered patents and preprints on recognized servers may be included in reference lists, but text, grant details and acknowledgements may not. Authors are responsible for obtaining permission to quote personal communications and unpublished data from the cited colleagues. Authors are responsible for the accuracy of cited references and these should be checked before submitting.
Citing references in the text
Formatting the references list
UNPUBLISHED WORK SHOULD NOT BE INCLUDED IN THE LIST OF REFERENCES. REFERENCES SHOULD BE LISTED USING THE FOLLOWING ORDER:
Journal Article: If there are more than 10 authors, only the first 3 should be listed and the others should be represented with “et al.,”
Adamude FA, Onyekachi MK. In vivo anti-diarrhoeal activity of methanol extract of Bombax buonopozense. Universal Journal of Pharmaceutical Research 2017; 2(1): 1-4. http://doi.org/10.22270/ujpr.v2i1.R1
Tables must be cited within the main text in numerical order (for example, “Table 1” or “Tables 2”). Titles should be short but descriptive. Tables should be created in Microsoft Word with the tables tool with real rows and columns. Tables should be plain with no colors, shading, or graphics. Symbols and abbreviations should be defined immediately below the table, followed by essential brief description.
Figures must be submitted as separate files, and NOT embedded in the main manuscript file. Figures must be cited within the main text in numerical order (for example “Figure 1” or “Figures 2”. The width of the figure should be about 8 cm to 16 cm and in figures, the font of words must be of “Times New Roman”. Multi-panel figures (with labeled parts as a, b, c, d, etc.) must be combined and uploaded as one file. In order to publish all figures as open access, authors must have permission from the rights holder if they wish to include images that have been published elsewhere in non-open-access journals.
FORMULA AND EQUATIONS:
Structural and chemical formula, process flow diagrams and complicated mathematical expressions should be very clearly presented. All subscripts, Greek letters and unusual characters must be identified. Structural and chemical formulae as well as process flow diagrams should be prepared in the same way as graphs.
Ethics approval and consent to participate
Authors of submissions reporting studies involving human participants, human data, or human tissues are required to provide the following information:
Submissions reporting studies involving animals must include a statement on ethics approval. If the submission contains any individual person’s data in any form, consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent to publish. The authors may use their institutional consent form. The form is not to be sent on submission, but we may request to see a copy at any stage (including after publication).
UJPR requires the corresponding author to sign a copyright transfer agreement on behalf of all the authors. Unless this agreement is received, the journal will not be able to publish the manuscript. The format of the copyright agreement may be downloaded from the journal site.
Abstracting & Indexing